3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
108
Carcinoma, Renal Cell
36
Melanoma
13
Kidney Neoplasms
13
Neoplasm Metastasis
11
Urinary Bladder Neoplasms
10
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Brain Neoplasms
9
Sarcoma
8
Lung Neoplasms
8
Prostate Cancer Metastatic
6
Neoplasms
5
Carcinoma, Transitional Cell
5
Adenocarcinoma
5
Prostate Adenocarcinoma
4
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Clear-cell metastatic renal cell carcinoma
3
Thyroid Neoplasms
2
Spinal Cord Compression
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oligometastatic Prostate Cancer
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphatic Metastasis
2
Local Recurrence of Malignant Tumor of Prostate
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Interventions
Radiosurgery
1
Deamino Arginine Vasopressin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Castrate Resistance Prostate Cancer
×
Radiosurgery
×
Genitourinary
×
Clear all
NCT06927635
2025-09-05
SECURE
University Health Network, Toronto
Phase 2
Recruiting
75 enrolled